Patient Square Capital has formed a new portfolio company called Elevage Medical Technologies, which will provide financial and strategic growth support to a range of medical device technology companies that are driving innovation in healthcare. Patient Square has committed $300 million to Elevage, which will be led by Evan Melrose, MD, a seasoned healthcare professional with over 25 years of experience in clinical, investment, and operational roles. The aim of Elevage is to help promising medical device companies to grow and achieve their potential by leveraging Patient Square’s expertise and resources.
What You Should Know:
Healthcare investment firm Patient Square Capital (“Patient Square”) forms Elevage Medical Technologies (“Elevage”), a new portfolio company to support the growth of promising medical device companies by providing capital and deep strategic expertise.
Elevage will deliver financial and strategic growth support to a broad set of medical device technology companies that are at the forefront of transforming health care through cutting-edge devices that enhance health outcomes and quality of life for patients. Patient Square has made a capital commitment of $300M to Elevage Medical Technologies.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Elevage will be led by newly appointed CEO Evan Melrose, M.D., who brings more than 25 years of experience in health care across clinical, investment, and operational roles.
Source: HitConsultant